It has been found that tumor specificity leads to higher survival chances in patients with colon cancer.
They say location is everything. So the side on which tumors exist in case of colon cancer patients is crucial in whether or not these patients will survive or not. The study was spearheaded by an oncologist. Those whose metastatic colon cancer was concentrated on the left side survived more than those whose tumors were on the right side. As if this were not enough, a specialized drug for colon cancer was irrelevant if the tumor was on the right side.
Don't Miss: The Best HDR TVs
The clinical trials prove that colon cancer is not one but many diseases. The latest evidence proves that the sort of colon cancer that exists on the right side is radically different from the sort that exists on the left side.
The research on the matter is all set to be released. All forms of colon cancer are not the same. The biologies of the two sides are worlds apart. The location of the tumor is what determines the course of the disease. The implications for tumor growth in colon cancer will not be the same in the future.
This knowledge changes everything. Over 30,000 oncologists will gather to discuss key issues in this year’s ASCO meeting which will be held in Chicago.
Of the 5200 abstracts chosen for the conference, at least 5 will have special status. One of these five is the colon cancer abstract. Genomes play an important role in the study of colon cancer.
The medicine and palliative measures will have to be precision-based. The lethal disease requires all the drugs and chemotherapy in the world to alleviate its symptoms.
Earlier studies are being supplanted by new data. What was standard practice in the past is giving way to novel procedures that are more honed towards treatment without extensive damage to surrounding tissues.
Usually, patients who are diagnosed with this disease are given a 29 month period before the terminal illness claims their lives. Only 10% of the patients live for half a decade.
They are the luckier ones. The prognosis was very dismal two decades ago. Over half of the patients were men. Those with tumors on the left side survived for 33.3 months.
Buy Now: Sony PlaysStation VR In Stock Here
Meanwhile those with a tumor on the right side survived for 19.4 months. The ultimate thing to take back from this study is that sides matter in colon cancer.